|
Condensed Separate Interim Cash flows for the period ended September 30, 2020
|
|
|
|
|
|
|
|
|
|
|
Notes
|
Sep. 30, 2020
|
|
Sep. 30, 2019
|
|
|
|
|
EGP Thousands
|
|
EGP Thousands
|
|
|
|
|
|
|
|
|
|
Cash flow from operating activities
|
|
|
|
|
|
|
Profit before income tax
|
|
11,290,726
|
|
11,777,254
|
|
|
Adjustments to reconcile net profit to net cash provided by operating activities
|
|
|
|
|
|
|
Fixed assets depreciation
|
14
|
503,005
|
|
425,637
|
|
|
Impairment charge for credit losses (Loans and advances to customers and banks)
|
|
3,761,572
|
|
1,256,000
|
|
|
Other provisions charges
|
17
|
972,522
|
|
12,494
|
|
|
Impairment charge for credit losses (due from banks)
|
|
12,395
|
|
23,161
|
|
|
Impairment charge for credit losses (financial investments)
|
|
88,192
|
|
(71,846)
|
|
|
Impairment charge for other assets
|
|
56,245
|
|
83,213
|
|
|
Exchange revaluation differences for financial assets at fair value through OCI
|
|
238,906
|
|
1,303,741
|
|
|
Intangible assets amortization
|
|
-
|
|
97,656
|
|
|
Impairment charge financial assets at fair value through OCI
|
|
79,126
|
|
45,664
|
|
|
Utilization of other provisions
|
17
|
(1,479)
|
|
(27,733)
|
|
|
Other provisions no longer used
|
17
|
(6,022)
|
|
(96,499)
|
|
|
Exchange differences of other provisions
|
17
|
(17,670)
|
|
(103,531)
|
|
|
(Profits) losses from selling property, plant and equipment
|
|
(872)
|
|
(1,439)
|
|
|
(Profits) losses from selling financial investments
|
12
|
(979,144)
|
|
(310,329)
|
|
|
Shares based payments
|
|
447,694
|
|
371,997
|
|
|
Released (Impairment) charges of investments in associates and subsidiaries
|
|
14,100
|
|
-
|
|
|
Operating profits before changes in operating assets and liabilities
|
|
16,459,296
|
|
14,785,440
|
|
|
|
|
|
|
|
|
|
Net decrease (increase) in assets and liabilities
|
|
|
|
|
|
|
Due from banks
|
|
(5,824,055)
|
|
(13,052,086)
|
|
|
Treasury bills and other governmental notes
|
|
(4,325,377)
|
|
4,974,205
|
|
|
Financial assets at fair value through P&L
|
12
|
74,562
|
|
2,252,280
|
|
|
Derivative financial instruments
|
|
(4,144)
|
|
(67,282)
|
|
|
Loans and advances to banks and customers
|
10 - 11
|
(2,311,001)
|
|
(4,796,325)
|
|
|
Other assets
|
|
653,639
|
|
247,536
|
|
|
Due to banks
|
15
|
(2,999,346)
|
|
(5,431,711)
|
|
|
Due to customers
|
16
|
26,727,228
|
|
22,543,760
|
|
|
Income tax obligations paid
|
|
(4,389,254)
|
|
(3,625,579)
|
|
|
Other liabilities
|
|
(4,645,456)
|
|
1,862,133
|
|
|
Net cash used in (generated from) operating activities
|
|
19,416,092
|
|
19,692,371
|
|
|
|
|
|
|
|
|
|
Cash flow from investing activities
|
|
|
|
|
|
|
Proceeds from investments in associates.
|
|
750
|
|
-
|
|
|
Payments for investment in subsidiaries and associates.
|
|
(680,836)
|
|
-
|
|
|
Payment for purchases of property, plant, equipment and branches
constructions
|
|
(809,475)
|
|
(1,066,607)
|
|
|
Proceeds from selling property, plant and equipment
|
|
872
|
|
1,439
|
|
|
Proceeds from redemption of financial assets at amortized cost
|
|
37,493,345
|
|
33,937,957
|
|
|
Payment for purchases of financial assets at amortized cost
|
|
-
|
|
(47,344,534)
|
|
|
Payment for purchases of financial assets at fair value through OCI
|
|
(51,331,273)
|
|
(26,637,577)
|
|
|
Proceeds from selling financial assets at fair value through OCI
|
|
24,096,252
|
|
5,354,858
|
|
|
Net cash generated from (used in) investing activities
|
|
8,769,635
|
|
(35,754,464)
|
|
|
|
|
|
|
|
|
|
|
|
Cash flow from financing activities
|
|
|
|
|
|
|
Increase (decrease) in long term loans
|
|
4,492,249
|
|
(321,235)
|
|
|
Dividend paid
|
|
(3,370,464)
|
|
(2,700,544)
|
|
|
Capital increase
|
|
85,992
|
|
-
|
|
|
Net cash generated from (used in) financing activities
|
|
1,207,777
|
|
(3,021,779)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalent during the period
|
|
29,393,504
|
|
(19,083,872)
|
|
|
Beginning balance of cash and cash equivalent
|
|
22,895,017
|
|
34,303,645
|
|
|
Cash and cash equivalent at the end of the period
|
|
52,288,521
|
|
15,219,773
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalent comprise:
|
|
|
|
|
|
|
Cash and balances at the central bank
|
7
|
35,579,884
|
|
27,205,020
|
|
|
Due from banks
|
|
56,274,241
|
|
25,629,602
|
|
|
Treasury bills and other governmental notes
|
9
|
31,967,018
|
|
44,736,504
|
|
|
Obligatory reserve balance with CBE
|
7
|
(29,856,359)
|
|
(20,770,245)
|
|
|
Due from banks with maturities more than three months
|
|
(8,958,909)
|
|
(16,541,989)
|
|
|
Treasury bills with maturity more than three months
|
|
(32,717,354)
|
|
(45,039,119)
|
|
|
Total cash and cash equivalent
|
|
52,288,521
|
|
15,219,773
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Separate Interim statement of changes in shareholders' equity for the period ended September 30, 2019
|
|
Sep. 30, 2019
|
Issued and paid up capital
|
Legal reserve
|
General reserve
|
General risk reserve
|
Capital reserve
|
Reserve for financial assets at fair value through OCI
|
Banking risks reserve
|
Retained earnings
|
Reserve for employee stock ownership plan
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
EGP Thousands
|
|
Beginning balance
|
11,668,326
|
1,710,293
|
12,776,215
|
1,549,445
|
12,421
|
(1,860,851)
|
4,323
|
9,555,755
|
738,320
|
36,154,247
|
|
Capital increase
|
2,917,082
|
-
|
(2,917,082)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Transferred to reserves
|
-
|
477,736
|
6,375,589
|
-
|
1,045
|
-
|
-
|
(6,854,370)
|
-
|
-
|
|
Dividend paid
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(2,700,544)
|
-
|
(2,700,544)
|
|
Net profit for the period
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
8,541,122
|
-
|
8,541,122
|
|
Net unrealised gain/(loss) on financial assets at fair value through OCI
|
-
|
-
|
-
|
-
|
-
|
5,271,372
|
-
|
-
|
-
|
5,271,372
|
|
Transferred (from) to bank risk reserve
|
-
|
-
|
-
|
-
|
-
|
-
|
841
|
(841)
|
-
|
-
|
|
ECL for impairment of debt instruments investments
|
-
|
-
|
-
|
-
|
-
|
(71,846)
|
-
|
-
|
-
|
(71,846)
|
|
Cost of employees stock ownership plan (ESOP)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
371,997
|
371,997
|
|
Ending balance
|
14,585,408
|
2,188,029
|
16,234,722
|
1,549,445
|
13,466
|
3,338,675
|
5,164
|
8,541,122
|
1,110,317
|
47,566,348
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Separate Interim statement of changes in shareholders' equity for the period ended September 30, 2020
|
|
Sep. 30, 2020
|
Issued and paid up capital
|
Legal reserve
|
General reserve
|
General risk reserve
|
Capital reserve
|
Reserve for financial assets at fair value through OCI
|
Banking risks reserve
|
Retained earnings
|
Reserve for employee stock ownership plan
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
EGP Thousands
|
|
Beginning balance
|
14,690,821
|
2,188,029
|
16,474,429
|
1,549,445
|
13,466
|
4,111,781
|
5,164
|
11,803,555
|
963,152
|
51,799,842
|
|
Capital increase
|
85,992
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
85,992
|
|
Transferred to reserves
|
-
|
590,106
|
7,840,287
|
-
|
1,440
|
-
|
-
|
(8,431,833)
|
-
|
-
|
|
Dividend paid
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,370,464)
|
-
|
(3,370,464)
|
|
Net profit for the period
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
7,395,567
|
-
|
7,395,567
|
|
Transferred from reserve for financial assets at fair value through OCI
|
-
|
-
|
-
|
-
|
-
|
(76,717)
|
-
|
76,717
|
-
|
-
|
|
Net unrealised gain/(loss) on financial assets at fair value through OCI
|
-
|
-
|
-
|
-
|
-
|
(2,290,581)
|
-
|
-
|
-
|
(2,290,581)
|
|
Transferred (from) to bank risk reserve
|
-
|
-
|
-
|
-
|
-
|
-
|
1,259
|
(1,259)
|
-
|
-
|
|
Release provision for impairment of debt instruments investments
|
-
|
-
|
-
|
-
|
-
|
88,192
|
-
|
-
|
-
|
88,192
|
|
Cost of employees stock ownership plan (ESOP)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
447,694
|
447,694
|
|
Ending balance
|
14,776,813
|
2,778,135
|
24,314,716
|
1,549,445
|
14,906
|
1,832,675
|
6,423
|
7,472,283
|
1,410,846
|
54,156,242
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|